These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 18367252)

  • 1. Attenuated cytokine responses in porcine lymph node cells stimulated with CpG DNA are associated with low frequency of IFNalpha-producing cells and TLR9 mRNA expression.
    Dar A; Nichani AK; Benjamin P; Lai K; Soita H; Krieg AM; Potter A; Babiuk LA; Mutwiri GK
    Vet Immunol Immunopathol; 2008 Jun; 123(3-4):324-36. PubMed ID: 18367252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Innate immune responses induced by classes of CpG oligodeoxynucleotides in ovine lymph node and blood mononuclear cells.
    Booth JS; Nichani AK; Benjamin P; Dar A; Krieg AM; Babiuk LA; Mutwiri GK
    Vet Immunol Immunopathol; 2007 Jan; 115(1-2):24-34. PubMed ID: 17067685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characteristics of oligodeoxyribonucleotides that induce interferon (IFN)-alpha in the pig and the phenotype of the IFN-alpha producing cells.
    Domeika K; Magnusson M; Eloranta ML; Fuxler L; Alm GV; Fossum C
    Vet Immunol Immunopathol; 2004 Sep; 101(1-2):87-102. PubMed ID: 15261695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Toll-like receptor 9 in cpG oligodeoxynucleotides-induced species-specific immune responses].
    Li N; Fan XG; Tang SE; Zhu C
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2005 Oct; 30(5):533-5. PubMed ID: 16320582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of class A, B and C CpG-oligodeoxynucleotides on in vitro activation of innate immune cells in human immunodeficiency virus-1 infected individuals.
    Martinson JA; Tenorio AR; Montoya CJ; Al-Harthi L; Gichinga CN; Krieg AM; Baum LL; Landay AL
    Immunology; 2007 Apr; 120(4):526-35. PubMed ID: 17343615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Modulation of TLR9 on anti-tumor immune responses of peripheral blood mononuclear cells from patients with non-small-cell lung cancer].
    Ren T; Cai YY; Liang YJ; Jin ML; Guo ZL; Tao MF; He X
    Zhonghua Yi Xue Za Zhi; 2008 Apr; 88(17):1168-72. PubMed ID: 18844109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The immunostimulatory effect of CpG oligodeoxynucleotides on peripheral blood mononuclear cells of healthy dogs and dogs with atopic dermatitis.
    Jassies-van der Lee A; Rutten V; Spiering R; van Kooten P; Willemse T; Broere F
    Vet J; 2014 Apr; 200(1):103-8. PubMed ID: 24461202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunostimulatory Properties of Lipid Modified CpG Oligonucleotides.
    Yu C; An M; Li M; Liu H
    Mol Pharm; 2017 Aug; 14(8):2815-2823. PubMed ID: 28686452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cross-talk between toll-like receptors 5 and 9 on activation of human immune responses.
    Merlo A; Calcaterra C; Mènard S; Balsari A
    J Leukoc Biol; 2007 Sep; 82(3):509-18. PubMed ID: 17586660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. All three classes of CpG ODNs up-regulate IP-10 gene in pigs.
    Dar A; Nichani A; Lai K; Potter A; Gerdts V; Babiuk LA; Mutwiri G
    Res Vet Sci; 2010 Apr; 88(2):242-50. PubMed ID: 19896155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of DNA-PKcs in the type I IFN response to CpG-ODNs in conventional dendritic cells in TLR9-dependent or -independent manners.
    Ma C; Spies NP; Gong T; Jones CX; Chu WM
    PLoS One; 2015; 10(3):e0121371. PubMed ID: 25812014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential immunological adjuvant of `K'-type CpG-oligodeoxynucleotides enhanced the cell proliferation and IL-6 mRNA transcription in canine B cells.
    Kawarai S; Sato K; Horiguchi A; Kurata K; Kiuchi A; Tsujimoto H; Sakaguchi M
    J Vet Med Sci; 2011 Feb; 73(2):177-84. PubMed ID: 20877154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A threshold level of TLR9 mRNA predicts cellular responsiveness to CpG-ODN in haematological and non-haematological tumour cell lines.
    Assaf A; Esteves H; Curnow SJ; Browning MJ
    Cell Immunol; 2009; 259(1):90-9. PubMed ID: 19573862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinct responses of lung and spleen dendritic cells to the TLR9 agonist CpG oligodeoxynucleotide.
    Chen L; Arora M; Yarlagadda M; Oriss TB; Krishnamoorthy N; Ray A; Ray P
    J Immunol; 2006 Aug; 177(4):2373-83. PubMed ID: 16887999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytosine-phosphate-guanine oligodeoxynucleotides containing GACGTT motifs enhance the immune responses elicited by keyhole limpet hemocyanin antigen in dairy cattle.
    Chu CY; Lee SC; Liu SS; Lin YM; Shen PC; Yu C; Lee KH; Zhao X; Lee JW
    Nucleic Acid Ther; 2011 Oct; 21(5):323-32. PubMed ID: 21916610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CpG ODN 2102 promotes antibacterial immune responses and enhances vaccine-induced protection in golden pompano (Trachinotusovatus).
    Chen X; Wu Y; Qiu Y; Li P; Cao Z; Zhou Y; Sun Y
    Fish Shellfish Immunol; 2023 Jun; 137():108783. PubMed ID: 37137380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deoxycytidyl-deoxyguanosine oligonucleotide classes A, B, and C induce distinct cytokine gene expression patterns in rhesus monkey peripheral blood mononuclear cells and distinct alpha interferon responses in TLR9-expressing rhesus monkey plasmacytoid dendritic cells.
    Abel K; Wang Y; Fritts L; Sanchez E; Chung E; Fitzgerald-Bocarsly P; Krieg AM; Miller CJ
    Clin Diagn Lab Immunol; 2005 May; 12(5):606-21. PubMed ID: 15879022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CpG oligodeoxynucleotides block human immunodeficiency virus type 1 replication in human lymphoid tissue infected ex vivo.
    Schlaepfer E; Audigé A; von Beust B; Manolova V; Weber M; Joller H; Bachmann MF; Kundig TM; Speck RF
    J Virol; 2004 Nov; 78(22):12344-54. PubMed ID: 15507621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The newly identified CpG-N ODN208 protects mice from challenge with CpG-S ODN by decreasing TNF-alpha release.
    Wang L; Jiang W; Ding G; Cao H; Lu Y; Luo P; Zhou H; Zheng J
    Int Immunopharmacol; 2007 May; 7(5):646-55. PubMed ID: 17386412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunostimulatory Activities of CpG-Oligodeoxynucleotides in Teleosts: Toll-Like Receptors 9 and 21.
    Lai CY; Yu GY; Luo Y; Xiang R; Chuang TH
    Front Immunol; 2019; 10():179. PubMed ID: 30800129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.